2016
DOI: 10.1016/j.biochi.2015.06.018
|View full text |Cite
|
Sign up to set email alerts
|

Effect of selective estrogen receptor modulators on metabolic homeostasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
19
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(21 citation statements)
references
References 78 publications
1
19
0
1
Order By: Relevance
“…For instance, continuous stimulation of the mammary gland by E2 is associated with the development and progression of breast cancer (13). Estrogen receptor α (ERα) is a member of the nuclear receptor superfamily of transcription factors that act as key mediators of estrogen activity (14,15). Moreover, ERα has previously been demonstrated to regulate cell proliferation, differentiation and homeostasis in numerous tissues, and play a critical role in determining a prognosis or therapeutic strategy for breast cancer (16).…”
Section: Introductionmentioning
confidence: 99%
“…For instance, continuous stimulation of the mammary gland by E2 is associated with the development and progression of breast cancer (13). Estrogen receptor α (ERα) is a member of the nuclear receptor superfamily of transcription factors that act as key mediators of estrogen activity (14,15). Moreover, ERα has previously been demonstrated to regulate cell proliferation, differentiation and homeostasis in numerous tissues, and play a critical role in determining a prognosis or therapeutic strategy for breast cancer (16).…”
Section: Introductionmentioning
confidence: 99%
“…Diminished bone formation by osteoblasts or excessive bone resorption by osteoclasts results in osteoporosis (4). In postmenopausal women, osteoporosis is induced by a decrease in the production of estrogen, which is known to maintain the appropriate ratio of osteoblasts to osteoclasts (5,6). To treat postmenopausal osteoporosis, the most widely prescribed medications are bisphosphonates such as alendronate and zolendronic acid, although their longterm administration may increase the incidence of osteonecrosis of the jawbone and fracture of the femur (7,8).…”
mentioning
confidence: 99%
“…After menopause, women's estrogen levels decreased significantly, estrogen through the estrogen receptor (ER) directly effect on the osteoblast and osteoclasts, lead to imbalance of bone resorption and bone formation, resulting in reduced bone mass and BMD, increased bone fragility and the occurrence of osteoporosis (31,32). The decrease of estrogen level and the decrease of the expression of ER in bone tissue are one of the most important pathogenesis.…”
Section: Discussionmentioning
confidence: 99%